Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (391-400 of 434) with videos related to

Pageof 44
Sort By:
Journal of Neurology|March 13, 2024
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational studyRuth Geraldes, Monica Santos, Cristina Ponte, et al.
The Journal of Rheumatology|March 18, 2014
Updating the OMERACT filter: core areas as a basis for defining core outcome setsJohn R Kirwan, Maarten Boers, Sarah Hewlett, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Pageof 44

Showing results (391-400 of 434) with videos related to

Sort By:
Pageof 44
Journal of Neurology|March 13, 2024
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational studyRuth Geraldes, Monica Santos, Cristina Ponte, et al.
The Journal of Rheumatology|March 18, 2014
Updating the OMERACT filter: core areas as a basis for defining core outcome setsJohn R Kirwan, Maarten Boers, Sarah Hewlett, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Pageof 44